Merck & Company, Inc. 🇺🇸
MRK • Technology • USA
💡 Institutional Quantitative Investment Thesis
High-quality compounder passing 6/9 fundamental checks. Strong balance sheet with Forward PER compression (54.8x vs 117.2x) and robust Free Cash Flow generation.
📊 Frequently Asked Questions & Related Moat Stocks
1. What is Merck & Company, Inc. (MRK)'s Economic Moat Score in 2026?
In 2026, Merck & Company, Inc. (MRK) holds a proprietary MoatPicks Economic Moat Score™ of 87.0/100 (Wide Economic Moat). This 12-point fundamental audit evaluates MRK's 75.9% gross margin, $15.2B free cash flow generation, +5.1% YoY revenue growth, and 1.9x Debt/EBITDA ratio. You can benchmark any stock's competitive durability interactively with our Economic Moat Score™ Checker.
2. Is MRK stock undervalued right now based on P/E and PEG ratio?
Merck & Company, Inc. (MRK) commands a quality valuation premium at a Forward P/E of 54.8x and PEG ratio of 3.04x, reflecting its 75.9% gross margin and fortress cash flows. At a share price of $145.27, investors can stress-test MRK's fair value using the MoatPicks Economic Moat Score™ Checker and FIRE compounding calculators. Model how compounding MRK fits your long-term retirement target in our FIRE Financial Independence Calculator.
3. Which superinvestors and 13F hedge funds own MRK stock?
Merck & Company, Inc. (MRK) is actively monitored across our 25 tracked 13F superinvestor portfolios and institutional quality screens. Institutional capital focuses on MRK's 75.9% gross margin, $15.2B free cash flow, and 1.9x Debt/EBITDA balance sheet.